AlphAIAlphAI — Financial news for AI agents
investing.comOCT 132 min read$MI

NFT Limited releases verification protocol for digital commerce

NFT Limited (NYSE American: MI) launched RWAIX, a protocol to verify digital transactions. The company plans a 90-day pilot for its digital art platform, integrating RWAIX. Testing showed 50 successful tests. No tokens have been issued. CEO Yanying Wang aims to make the platform trustworthy. The pilot will use existing bank systems, with no cryptocurrency involved.

Original reporting
investing.com
Published Oct 13, 2026, 1:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 1:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefTechnology
Primary signal
$MI
Neutral
medium confidence
Mentioned
$MI
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$MINeutralLow
01

Why it matters

The announcement provides the first public details of RWAIX, a shared record‑keeping system aimed at improving trust in NFT trades. While the rollout is modest, successful pilot results could boost the company's credibility and user base.

02

Market read

Primary micro‑cap news with limited immediate market impact; relevance hinges on pilot success and industry adoption.

03

What to watch

Potential regulatory scrutiny of verification standards and competition from larger platforms.

Relevance 5/10Novelty 5/10Timing: pilot start Q1 2027

Background

NFT Limited (MI) runs an online marketplace for digital art and collectibles and is introducing a new technical protocol for transaction verification.

Company-level read

Ticker impact

$MINeutralMedium confidence
Context

NFT Limited announced its RWAIX verification protocol and a pilot launch plan, representing the first public disclosure of this product.

Expected impact

modest upside as market prices in the protocol rollout and pilot progress

Evidence & confidence

Small‑cap news with limited immediate financial impact; price may move gradually with pilot results.

Market effects

Sector

May signal growing emphasis on verification standards in the NFT and digital collectibles space.

Regional

Limited to markets where NFT Limited operates, primarily Hong Kong and US investors.

Global

Low global impact; niche relevance to digital art platforms.

Counterpoint

What could challenge this read

The protocol may be too early or lack adoption, limiting any price benefit.

Key entities

  • company
    NFT Limited

    Operator of a digital art and collectibles trading platform.

  • product
    RWAIX

    Technical protocol for identity, agreement, and delivery verification in digital transactions.

Read at source← All news

Related articles

MAY 25
$MIMedAI 9/10

2 Canadian Stocks to Own If Housing Cools (or Re-Accelerates)

The article highlights Primaris REIT (TSX:PMZ.UN) and Minto Apartment REIT (TSX:MI.UN) as Canadian real-estate dividend plays tied to housing-cycle shifts. Primaris reported Q1 2026 net income of $41.9M, FFO per diluted unit of $0.425, and $0.88 annualized distribution (~4.5% yield). Minto reported Q1 2026 revenue of $39.4M (+3.7%) and normalized FFO/unit of $0.2371 (+7.4%), but occupancy fell to 93.7%. It also notes Crestpoint agreed to buy Minto units for $18 cash, expected in H2 2026.

fool.ca6 min
OCT 22
$ABBVMedAI 8/10

Great News for AbbVie Stock Investors

AbbVie (NYSE:ABBV) shares have risen 26% this year due to strong financial performance. The company's growth is driven by Skyrizi and Rinvoq, with Skyrizi generating $10B in H1 sales. AbbVie is developing ABBV-466, a potential successor to Skyrizi, and acquired Apogee Therapeutics for $10.9B to bolster its immunology portfolio. The company also has a strong pipeline and a 2.5% dividend yield.

finance.yahoo.com3 min
OCT 22
$MRKHighAI 8/10

RBC Capital reiterates Merck stock rating on melanoma trial data

RBC Capital reiterated a Sector Perform rating and $145 price target for Merck (MRK) after melanoma trial data showed a recurrence-free survival hazard ratio of 0.58. The stock is near its 52-week high, up 76% year-to-date. Analysts expect regulatory filings in the U.S. and Europe, with FDA approval anticipated in 2027. Merck is set to announce earnings on October 29, with mixed analyst expectations.

investing.com2 min
OCT 22
$JPMMed

JPMorgan Is Blocking Outside AI Agents and Taking Its Deposit Token to Ethereum. Here’s What Both Moves Protect

JPMorgan Chase (JPM) blocked outside AI agents from moving customer deposits and expanded its JPM Coin to Ethereum for institutional clients. The bank's 2027 interest income outlook relies heavily on deposit and card-loan growth. Shares closed at $335.19, up 4.0% in 2026. Q3 earnings missed estimates, with adjusted EPS of $5.75 vs. $5.94 expected. Analysts' target price is ~$373, with a potential total return of ~31%.

finance.yahoo.com2 min
OCT 22
$GMMed

‘Propulsion-Agnostic’: GM Wants To Bring Tesla-Style Software Features To Its Gas SUVs, Too

General Motors (GM) announced a new centralized computing architecture for its vehicles, supporting both gas and electric powertrains. The system, debuting in the 2028 Cadillac Escalade IQ, aims to reduce complexity, improve software features, and enhance connectivity. GM claims 40x more computing power, 30% less wiring, and 50% faster cellular connectivity. The move is part of GM's strategy to compete with Tesla and other automakers in offering advanced software-defined vehicle features.

insideevs.com2 min